Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT)

Arcutis Biotherapeutics is a commercial-stage medical dermatology company dedicated to developing meaningful innovations for those living with immune-mediated skin diseases and conditions. Committed to addressing the most persistent challenges in dermatology, Arcutis boasts a growing portfolio of three FDA-approved products that leverage their unique dermatology development platform and expertise. This platform fuels a robust pipeline of multiple clinical programs focused on inflammatory dermatological conditions such as scalp and body psoriasis, atopic dermatitis, and alopecia areata.

Arcutis prioritizes patient needs and a commitment to diversity and inclusion. They foster a culture of accountability, transparency, and respect, aiming to create a positive impact on the world through ethical and environmentally responsible business practices. They are recognized for their dedication to patient care, as evidenced by their patient assistance program, which provides medication at no cost to eligible individuals. This focus on patient access and a strong emphasis on ethical practices distinguish Arcutis within the biopharmaceutical industry.

Arcutis offers a variety of flexible work arrangements, including flexible PTO for vacations, personal business, and family concerns. They also offer a discounted Employee Stock Purchase Plan and a 401K with up to a 4% match of employee contribution. The company provides medical, dental, and vision plans with generous company cost sharing, as well as Flexible Spending and Health Savings Accounts with an employer contribution.

Arcutis Biotherapeutics offers a comprehensive benefits package to its employees, including flexible paid time off for various reasons, a 401(k) plan with a generous company match, and discounted employee stock purchase plans. They also provide medical, dental, and vision insurance with company cost-sharing, as well as flexible spending and health savings accounts with employer contributions. Additionally, they offer non-taxable reimbursements for mobile phone plans and gym memberships, promoting employee wellness.

Arcutis Biotherapeutics is a commercial-stage medical dermatology company focused on developing meaningful innovations in immuno-dermatology to address the urgent needs of individuals living with immune-mediated dermatological diseases and conditions. They are committed to solving the most persistent patient challenges in dermatology by developing differentiated therapies against biologically validated targets. Their dermatology development platform includes a robust pipeline with multiple clinical programs for a range of inflammatory dermatological conditions.

Arcutis Biotherapeutics fosters a culture deeply rooted in meaningful innovation, patient-centricity, and ethical conduct. They prioritize diversity and inclusion, valuing varied perspectives in all aspects of their work. The company emphasizes accountability, empowerment, and transparency, creating a collaborative environment where results matter more than activity. Arcutis strives to be an upstanding global citizen, committed to ethical standards and making a positive impact in the world.

Arcutis Biotherapeutics prioritizes diversity, equity, and inclusion across all aspects of its operations. These values are deeply embedded in its culture, from hiring practices to clinical trial design and execution. Arcutis believes that a diverse and inclusive workforce leads to better outcomes for patients, providers, and employees. The company strives to ensure adequate diversity in clinical trial populations, actively working to reduce barriers, improve access, and raise awareness of the clinical trial process among underrepresented groups. Arcutis is committed to fostering a culture of authenticity and employee well-being, supporting human connectivity and purpose within its community. This commitment to diversity and inclusion extends to all levels of the organization, including its board of directors.